Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Inmune Bio, Inc.
Vividion Therapeutics, Inc.
Children's Hospital of Philadelphia
Pfizer
Pheon Therapeutics
GlaxoSmithKline
Bristol-Myers Squibb
Elevation Oncology
Pfizer
Zymeworks BC Inc.
Astellas Pharma Inc
Amgen
Pfizer
Sanofi
Incyte Corporation
Pfizer
Masonic Cancer Center, University of Minnesota
iTeos Therapeutics
Cancer Trials Ireland
Actuate Therapeutics Inc.
Biomea Fusion Inc.
Advanced Accelerator Applications
Mirati Therapeutics Inc.
Celgene
Sanofi
German Cancer Research Center
Poseida Therapeutics, Inc.
Sanofi
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Biomea Fusion Inc.
Merck Sharp & Dohme LLC
Pfizer
NantBioScience, Inc.
AbbVie
Bexion Pharmaceuticals, Inc.
Mirati Therapeutics Inc.
Celularity Incorporated
Navire Pharma Inc., a BridgeBio company
Adaptimmune
Merck Sharp & Dohme LLC
Boehringer Ingelheim
Adaptimmune
Adaptimmune
Astellas Pharma Inc
EpicentRx, Inc.
Celgene
University of Utah
Altor BioScience